Indeed, our findings establish FAK as an essential player that facilitates the oncogenic conversion of TGF-β in developing and progressing mammary tumors, leading to their acquisition of invasive and metastatic phenotypes in response to TGF-β. Here, PTK2 is linked to breast cancer.